Evidence map›Paper›PMID 35216494›Full record

ArticleInternational journal of molecular sciences2022

A Zebrafish Model for a Rare Genetic Disease Reveals a Conserved Role for FBXL3 in the Circadian Clock System.

Shir Confino, Talya Dor, Adi Tovin, Yair Wexler, Zohar Ben-Moshe Livne, Michaela Kolker, Odelia Pisanty, Sohyun Kathy Park, Nathalie Geyer, Joel Reiter and 7 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Zebrafish as a Model for Neurological Disorders.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Shir ConfinoSchool of Neurobiology, Biochemistry and Biophysics, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Talya DorPediatric Neurology Unit, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Adi TovinThe Faculty of Life Sciences and the Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan 5290002, Israel.
Yair WexlerSchool of Neurobiology, Biochemistry and Biophysics, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Zohar Ben-Moshe LivneSchool of Neurobiology, Biochemistry and Biophysics, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Michaela KolkerSchool of Zoology, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Odelia PisantySchool of Neurobiology, Biochemistry and Biophysics, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Sohyun Kathy ParkInstitute of Biological and Chemical Systems, Karlsruhe Institute of Technology, 76344 Eggenstein-Leopoldshafen, Germany.
Nathalie GeyerInstitute of Biological and Chemical Systems, Karlsruhe Institute of Technology, 76344 Eggenstein-Leopoldshafen, Germany.
Joel ReiterPediatric Pulmonary & Sleep Unit, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel.ORCID 0000-0003-2565-4185
Shimon EdvardsonPediatric Neurology Unit, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Hagar Mor-ShakedDepartment of Genetics, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Orly ElpelegDepartment of Genetics, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel.
Daniela ValloneInstitute of Biological and Chemical Systems, Karlsruhe Institute of Technology, 76344 Eggenstein-Leopoldshafen, Germany.
Lior AppelbaumThe Faculty of Life Sciences and the Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan 5290002, Israel.ORCID 0000-0002-9248-5919
Nicholas S FoulkesInstitute of Biological and Chemical Systems, Karlsruhe Institute of Technology, 76344 Eggenstein-Leopoldshafen, Germany.
Yoav GothilfSchool of Neurobiology, Biochemistry and Biophysics, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Tel Aviv University · ILHebrew University of Jerusalem · ILKarlsruhe Institute of Technology · DEBar-Ilan University · IL

Funding

German-Israeli Foundation for Scientific Research and Development I-1320-203.13/2015Helmholtz funding program, BioInterfaces in Technology and MedicineIsrael Science Foundation 2462/20Israel Science Foundation 961/19
6 · The paper itself

Abstract

The circadian clock, which drives a wide range of bodily rhythms in synchrony with the day-night cycle, is based on a molecular oscillator that ticks with a period of approximately 24 h. Timed proteasomal degradation of clock components is central to the fine-tuning of the oscillator's period. FBXL3 is a protein that functions as a substrate-recognition factor in the E3 ubiquitin ligase complex, and was originally shown in mice to mediate degradation of CRY proteins and thus contribute to the mammalian circadian clock mechanism. By exome sequencing, we have identified a

Indexed as

AnimalsCircadian ClocksCircadian RhythmF-Box ProteinsGenetic Diseases, InbornHumansIntellectual DisabilityMammalsModels, AnimalMutationRare DiseasesZebrafishF-Box Proteinscircadian clockFBXL3rare genetic diseasezebrafish

Identifiers

PMID35216494
PMCPMC8875760
OpenAlexW4213175234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.